After a median follow-up of 16.5 months, none of the participants developed pancreatic cancer, and some of the precancerous lesions shrank or stopped growing.
Aacr.org
A Vaccine to Prevent Pancreatic Cancer in High-risk Individuals Was Safe and Elicited Durable Immune Responses
Read full article at Aacr.org
Disclaimer: This article summary is sourced from Aacr.org. HealthRankings provides this for informational purposes only. Always consult a qualified healthcare provider before making medical decisions.
More health news
ConsumerReports.org
No, You Shouldn’t Avoid Fruits and Vegetables Due to Cyclospora
23h ago
Fox News
Pancreatic cancer vaccine shows promise in first human trial, preventing disease in high-risk patients
Yesterday
USA Today
Fifth person dies in Legionnaires' disease outbreak in NYC neighborhood
Yesterday
CBS News